Product Code: 978-1-68038-265-5
Sleep Apnea Devices Market Growth & Trends:
The global sleep apnea devices market size is expected to reach USD 6.9 billion by 2030, according to a new report by Grand View Research, Inc. The market is anticipated to expand at a CAGR of 6.2% from 2022 to 2030. The growing prevalence of chronic disorders such as hypertension, diabetes, cardiovascular diseases, and obesity is increasing the incidence rate & burden of Obstructive Sleep Apnea (OSA).
According to World Population Review estimates, the prevalence of obesity in the U.S. accounts for 36.2% of the total population. As per studies, the prevalence of OSA increases with increasing age. The growing global geriatric population with increasing life expectancy is anticipated to contribute to the growing prevalence of OSA. Low awareness levels and poor penetration of apnea devices in developing and underdeveloped nations introduce potential growth opportunities.
The COVID-19 pandemic imposed multiple lockdowns and travel restrictions leading to significant disruptions in the functioning of healthcare facilities. Several healthcare facilities underwent significant infrastructural changes and healthcare providers were forced to postpone elective procedures. The pandemic impacted the procedural volume and led to the temporary shutdown of sleep centers, clinics, and physician practices. These measures to curb the transmission rate of coronavirus negatively impacted the diagnostics market growth.
However, therapeutic devices such as sleep & respiratory care witnessed a surge in demand during the initial months of the pandemic. Positive Airway Pressure devices were being used as an alternative to mechanical ventilation instead of ventilators.
Key players are constantly focusing on devising innovative product development strategies to serve the growing diagnostic and therapeutic demand which is driving growth. Furthermore, innovative alternatives to CPAP such as oral and nasal devices are being introduced for patients with a low tolerance for CPAP.
For instance, GoPAPFree, a manufacturer of homecare oral devices introduced O2Vent Optima in February 2021 as a convenient & more effective alternative to CPAP. Similarly, Fisher & Paykel launched F&P Evora with CapFit headgear in February 2020 which is a compact nasal mask used in sleep apnea treatment for European, Canadian, Australian, and New Zealand markets.
Sleep Apnea Devices Market Report Highlights:
- The therapeutic devices segment held the largest revenue share of 79.4%. in 2021
- North America accounted for the largest revenue share of 48.7% in 2021, owing to the growing prevalence of OSA, rising awareness levels, and presence of renowned players
- Asia Pacific is expected to witness the fastest CAGR of over 7.0% from 2022 to 2030, owing to the prevalence of OSA and the rising awareness in the region
Table of Contents
Chapter 1 Methodology and Scope
- 1.1 Market Segmentation and Scope
- 1.2 Market Definition
- 1.3 Research Methodology
- 1.3.1 Information Procurement
- 1.3.1.1 Purchased database
- 1.3.1.2 GVR's internal database
- 1.3.2 Primary Research
- 1.4 Research Scope and Assumptions
- 1.5 List to Data Sources
Chapter 2 Executive Summary
- 2.1 Global Sleep Apnea Devices Market Outlook
- 2.2 Global Sleep Apnea Devices Market Segment Outlook
- 2.3 Global Sleep Apnea Devices Market Competitive Insight
- 2.4 Global Sleep Apnea Snapshot
Chapter 3 Global Sleep Apnea Devices Market Variables, Trends, & Scope
- 3.1 Market Lineage Outlook
- 3.1.1 Parent market outlook
- 3.1.2 Related/ancillary market outlook
- 3.2 Penetration and Growth Prospect Mapping
- 3.3 Market Dynamics
- 3.3.1 Market Driver Analysis
- 3.3.2 Market Restraint Analysis
- 3.3.3 Industry Challenges
- 3.4 Global Sleep Apnea Devices Market Analysis Tools
- 3.4.1 Industry Analysis - Porter's
- 3.4.1.1 Bargaining power of the suppliers
- 3.4.1.2 Bargaining power of the buyers
- 3.4.1.3 Threats of substitution
- 3.4.1.4 Threats from new entrants
- 3.4.1.5 Competitive rivalry
- 3.4.2 PESTEL Analysis
- 3.4.2.1 Political landscape
- 3.4.2.2 Economic and Social landscape
- 3.4.2.3 Technology landscape
- 3.4.2.4 Legal landscape
- 3.4.2.5 Technology landscape
- 3.4.3 Regulatory Framework
- 3.4.3.1 Compliance Standards
- 3.4.4 Impact of COVID-19
Chapter 4 Global Sleep Apnea Devices Market: Competitive Analysis
- 4.1 Recent Developments & Impact Analysis, By Key Market Participants
- 4.2 Company Market Share Analysis
- 4.3 Company Market Position Analysis
Chapter 5 Global Sleep Apnea Devices Market: Product Type Estimates & Trend Analysis
- 5.1 Definitions & Scope
- 5.2 Global Sleep Apnea Devices Market: Product Type Market Share Analysis, 2021 and 2030
- 5.3 Diagnostic Devices
- 5.3.1 Diagnostic devices analysis market estimates and forecasts, 2016 - 2030 (USD Million)
- 5.3.2 Actigraphs analysis market estimates and forecasts, 2016 - 2030 (USD Million)
- 5.3.3 Polysomnography Device analysis market estimates and forecasts, 2016 - 2030 (USD Million)
- 5.3.4 Respiratory polygraphs analysis market estimates and forecasts, 2016 - 2030 (USD Million)
- 5.3.4.1 Cardiologists
- 5.3.4.2 ENT Specialists
- 5.3.4.3 Homecare Nurses
- 5.3.4.4 Sleep Physicians
- 5.3.5 Pulse oximeters analysis market estimates and forecasts, 2016 - 2030 (USD Million)
- 5.4 Therapeutic Devices
- 5.4.1 PAP devices market estimates and forecasts, 2016 - 2030 (USD Million)
- 5.4.4.1 Continuous Positive Airway Pressure (CPAP)
- 5.4.4.2 Auto - titrating Positive Airway Pressure (APAP)
- 5.4.4.3 Bilevel Positive Airway Pressure (BiPAP)
- 5.4.2 Oral devices market estimates and forecasts, 2016 - 2030 (USD Million)
- 5.4.3 Nasal devices market estimates and forecasts, 2016 - 2030 (USD Million)
- 5.4.4 Chin Straps market estimates and forecasts, 2016 - 2030 (USD Million)
- 5.5 Sleep Apnea Masks
Chapter 6 Global Sleep Apnea Devices Market: Regional Estimates & Trend Analysis, By Product Type
- 6.1 Global Sleep Apnea Devices Market: Regional Movement Analysis
- 6.2 North America
- 6.2.1 North America Sleep Apnea market estimates and forecasts, by Product Type, 2016 - 2030 (USD Million)
- 6.2.2 U.S.
- 6.2.2.1 U.S. Sleep Apnea market estimates and forecasts, by Product Type, 2016 - 2030 (USD Million)
- 6.2.3 Canada
- 6.2.3.1 Canada Sleep Apnea market estimates and forecasts, by Product Type, 2016 - 2030 (USD Million)
- 6.3 Europe
- 6.3.1 Europe Sleep Apnea market estimates and forecasts, by Product Type, 2016 - 2030 (USD Million)
- 6.3.2 U.K.
- 6.3.2.1 U.K. Sleep Apnea market estimates and forecasts, by Product Type, 2016 - 2030 (USD Million)
- 6.3.3 Germany
- 6.3.3.1 Germany Sleep Apnea market estimates and forecasts, by Product Type, 2016 - 2030 (USD Million)
- 6.3.4 France
- 6.3.4.1 France Sleep Apnea market estimates and forecasts, by Product Type, 2016 - 2030 (USD Million)
- 6.3.5 Italy
- 6.3.5.1 Italy Sleep Apnea market estimates and forecasts, by Product Type, 2016 - 2030 (USD Million)
- 6.3.6 Spain
- 6.3.6.1 Spain Sleep Apnea market estimates and forecasts, by Product Type, 2016 - 2030 (USD Million)
- 6.3.7 Russia
- 6.3.7.1 Russia Sleep Apnea market estimates and forecasts, by Product Type, 2016 - 2030 (USD Million)
- 6.3.8 Portugal
- 6.3.8.1 Portugal Sleep Apnea market estimates and forecasts, by Product Type, 2016 - 2030 (USD Million)
- 6.4 Asia Pacific
- 6.4.1 Asia Pacific Sleep Apnea market estimates and forecasts, by Product Type, 2016 - 2030 (USD Million)
- 6.4.2 Japan
- 6.4.2.1 Japan Sleep Apnea market estimates and forecasts, by Product Type, 2016 - 2030 (USD Million)
- 6.4.3 China
- 6.4.3.1 China Sleep Apnea market estimates and forecasts, by Product Type, 2016 - 2030 (USD Million)
- 6.4.4 India
- 6.4.4.1 India Sleep Apnea market estimates and forecasts, by Product Type, 2016 - 2030 (USD Million)
- 6.4.5 Australia
- 6.4.5.1 Australia Sleep Apnea market estimates and forecasts, by Product Type, 2016 - 2030 (USD Million)
- 6.4.6 South Korea
- 6.4.6.1 South Korea Sleep Apnea market estimates and forecasts, by Product Type, 2016 - 2030 (USD Million)
- 6.4.7 Singapore
- 6.4.7.1 Singapore Sleep Apnea market estimates and forecasts, by Product Type, 2016 - 2030 (USD Million)
- 6.5 Latin America
- 6.5.1 Latin America Sleep Apnea market estimates and forecasts, by Product Type, 2016 - 2030 (USD Million)
- 6.5.2 Brazil
- 6.5.2.1 Brazil Sleep Apnea market estimates and forecasts, by Product Type, 2016 - 2030 (USD Million)
- 6.5.3 Mexico
- 6.5.3.1 Mexico Sleep Apnea market estimates and forecasts, by Product Type, 2016 - 2030 (USD Million)
- 6.5.4 Argentina
- 6.5.4.1 Argentina Sleep Apnea market estimates and forecasts, by Product Type, 2016 - 2030 (USD Million)
- 6.6 MEA
- 6.6.1 MEA Sleep Apnea market estimates and forecasts, by Product Type, 2016 - 2030 (USD Million)
- 6.6.2 South Africa
- 6.6.2.1 South Africa Sleep Apnea market estimates and forecasts, by Product Type, 2016 - 2030 (USD Million)
- 6.6.3 Saudi Arabia
- 6.6.3.1 Saudi Arabia Sleep Apnea market estimates and forecasts, by Product Type, 2016 - 2030 (USD Million)
- 6.6.4 UAE
- 6.6.4.1 UAE Sleep Apnea market estimates and forecasts, by Product Type, 2016 - 2030 (USD Million)
Chapter 7 Competitive Landscape
- 7.1 BMC MEDICAL CO. LTD.
- 7.1.1 Company overview
- 7.1.2 Financial performance
- 7.1.3 Product benchmarking
- 7.1.4 Strategic initiatives
- 7.2 CAREFUSION CORP. (PART OF BECTON, DICKINSON, AND COMPANY)
- 7.2.1 Company overview
- 7.2.2 Financial performance
- 7.2.3 Product benchmarking
- 7.2.4 Strategic initiatives
- 7.3 GE HEALTHCARE
- 7.3.1 Company overview
- 7.3.2 Financial performance
- 7.3.3 Product benchmarking
- 7.3.4 Strategic initiatives
- 7.4 KONINKLIJKE PHILIPS N.V. (PHILIPS RESPIRONICS)
- 7.4.1 Company overview
- 7.4.2 Financial performance
- 7.4.3 Product benchmarking
- 7.4.4 Strategic initiatives
- 7.5 RESMED
- 7.5.1 Company overview
- 7.5.2 Financial performance
- 7.5.3 Product benchmarking
- 7.5.4 Strategic initiatives
- 7.6 COMPUMEDICS LIMITED
- 7.6.1 Company overview
- 7.6.2 Financial performance
- 7.6.4 Product benchmarking
- 7.6.4 Strategic initiatives
- 7.7 CURATIVE MEDICAL
- 7.7.1 Company overview
- 7.7.2 Financial performance
- 7.7.3 Product benchmarking
- 7.7.4 Strategic initiatives
- 7.8 FISHER & PAYKEL HEALTHCARE LIMITED
- 7.8.1 Company overview
- 7.8.2 Financial performance
- 7.8.3 Product benchmarking
- 7.8.4 Strategic initiatives
- 7.9 IMTHERA MEDICAL, INC. (PART OF LIVANOVA PLC)
- 7.9.1 Company overview
- 7.9.2 Financial performance
- 7.9.3 Product benchmarking
- 7.9.4 Strategic initiatives
- 7.10 INVACARE CORPORATION
- 7.10.1 Company overview
- 7.10.2 Financial performance
- 7.10.3 Product benchmarking
- 7.10.4 Strategic initiatives
- 7.11 ITAMAR MEDICAL LTD.
- 7.11.1 Company overview
- 7.11.2 Financial performance
- 7.11.4 Product benchmarking
- 7.11.4 Strategic initiatives
- 7.12 NIHON KOHDEN
- 7.12.1 Company overview
- 7.12.2 Financial performance
- 7.12.3 Product benchmarking
- 7.12.4 Strategic initiatives
- 7.13 NATUS MEDICAL INCORPORATED
- 7.13.1 Company overview
- 7.13.2 Financial performance
- 7.13.3 Product benchmarking
- 7.13.4 Strategic initiatives
- 7.14 SOMNETICS INTERNATIONAL, INC.
- 7.14.1 Company overview
- 7.14.2 Financial performance
- 7.14.3 Product benchmarking
- 7.14.4 Strategic initiatives
- 7.15 BRAEBON MEDICAL CORPORATION
- 7.15.1 Company overview
- 7.15.2 Financial performance
- 7.15.3 Product benchmarking
- 7.15.4 Strategic initiatives